Sponsor of the Day:
Jerkmate
https://www.atarabio.com/ptld/
Atara Biotherapeutics PTLD and EBV - Post-Transplant Lymphoproliferative Disease and epstein-barr...
Feb 27, 2023 - Post-transplant lymphoproliferative disease EBV+. - PTLD and EBV - PTLD Treatments.
atara biotherapeuticspost transplantepstein barrebvlymphoproliferative
https://investors.atarabio.com/
Atara Biotherapeutics (ATRA)
Atara is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions...
atara biotherapeutics atra
https://www.atarabio.com/about-ebv/
Understanding Epstein-Barr Virus (EBV) - Atara Biotherapeutics
Feb 23, 2023 - Research has shown the Epstein-Barr virus (EBV) may be involved in the development of (PTLD) and multiple sclerosis (MS).
epstein barr virusatara biotherapeuticsunderstandingebv
https://investors.atarabio.com/news-events/press-releases/detail/364/atara-biotherapeutics-announces-third-quarter-2024
Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress ::...
Tab-cel® U.S. BLA On-Track With PDUFA Target Action Date of January 15, 2025 First Patient Dosed for ATA3219 Non-Hodgkin’s Lymphoma Study;…...
announces third quarter2024 financial resultsatara biotherapeuticsoperationalprogress
https://investors.atarabio.com/atra-stock/faq
FAQ :: Atara Biotherapeutics (ATRA)
atara biotherapeutics atrafaq
https://investors.atarabio.com/financial-results
Financial Results :: Atara Biotherapeutics (ATRA)
atara biotherapeutics atrafinancial results